Periodic Reporting for period 1 - TransMetTOR (Investigating Translation and Metabolism in mTORC2-driven Cancer)

The identification of the genetic mutations responsible for the formation of cancers has paved the way for the development of new drugs which specifically attack cancer cells, resulting in significant improvement in patient outcome. However, tumor development also involves a...